Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemia
Authors
Keywords
-
Journal
SURGERY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-06
DOI
10.1016/j.surg.2023.09.043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
- (2022) Jason R.B. Dyck et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction
- (2022) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extracellular Vesicles Modulate Inflammatory Signaling in Chronically Ischemic Myocardium of Swine with Metabolic Syndrome
- (2022) Sharif A. Sabe et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021
- (2022) Megan Lindstrom et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
- (2021) Steffen Pabel et al. Current Heart Failure Reports
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-17: Friend or foe in organ fibrosis
- (2019) Kritika Ramani et al. CYTOKINE
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis
- (2019) Jun-Won Lee et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role and mechanism of cardiac insulin resistance in occurrence of heart failure caused by myocardial hypertrophy
- (2019) Liling Zheng et al. Aging-US
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
- (2019) Bryce C Simes et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Development of SGLT1 and SGLT2 inhibitors
- (2018) Timo Rieg et al. DIABETOLOGIA
- Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
- (2018) Silvio E. Inzucchi et al. CIRCULATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?
- (2017) Xingjuan Shi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin increases oxidative stress and modulates angiogenesis in Ossabaw swine with the metabolic syndrome
- (2012) Nassrene Y. Elmadhun et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Therapeutic neovascularization for coronary disease: current state and future prospects
- (2011) Antonio D. Lassaletta et al. BASIC RESEARCH IN CARDIOLOGY
- Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats
- (2010) Giselle C. Meléndez et al. HYPERTENSION
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started